Recover Losses: Ademi & O’Reilly, LLP Investigates Possible Securities Fraud of Osiris Therapeutics, Inc.


MILWAUKEE, Nov. 17, 2015 (GLOBE NEWSWIRE) -- We are investigating possible securities fraud claims against Osiris resulting from inaccurate statements Osiris made regarding its financial performance.

Click here to learn more about the investigation: http://www.ademilaw.com/case/osiris or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Our investigation focuses on the extent to which Osiris issued false and misleading statements regarding its financial statement, past and future business performance and prospects. Specifically, the investigation is related to Osiris’s recent disclosure in its 10-Q filing of financial restatements, described by one analyst as showing evidence of "aggressive accounting, particularly in regard to revenue recognition." 

If you wish to obtain additional information or have information about Osiris, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, http://www.ademilaw.com/case/osiris.                     

We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.


            

Contact Data